Clinical outcomes and safety of efgartigimod in Guillain–Barré syndrome: a retrospective observation study - Top-Institutions - MDSpire

Clinical outcomes and safety of efgartigimod in Guillain–Barré syndrome: a retrospective observation study

  • By

  • Yongli Tao

  • Ting Yang

  • Chenyang Jiang Jiang

  • Xue Wang

  • Liangliang Gu

  • Rui Zhang

  • June 19, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    First Affiliated Hospital of Zhengzhou University
    First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan

    Key Differentiators

    • Neurology

  • #2

    Nanyang Central Hospital
    Nanyang Central Hospital

    Nanyang, Henan

    Key Differentiators

    • Neurology

  • #3

    Second Affiliated Hospital of Army Medical University
    Second Affiliated Hospital of Army Medical University

    Chongqing, Chongqing

    Key Differentiators

    • Neurology

Original Source(s)

Clinical outcomes and safety of efgartigimod in Guillain–Barré syndrome: a retrospective observation study

  • by Yongli Tao, Ting Yang, Chenyang Jiang Jiang, Xue Wang, Liangliang Gu, Rui Zhang

  • June 19, 2026

Related Content

Case Report: Hybrid retrograde transcarotid stenting for common carotid artery dissection secondary to acute type A aortic dissection

Research advances and application prospects of CAR-T therapy in the treatment of age-related diseases

Cholinergic regulation of neuroinflammation: linking microglia, immunometabolism, and neuromodulation